News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
Synergistic alliance accelerates drug discovery
11-Jan-2001 - Bayer and Millennium Pharmaceuticals, Inc. today announced their joint success in employing a new research paradigm resulting in the rapid discovery of the first genome-derived small molecule drug candidate to emerge from the companies' joint research alliance. This novel compound is believed ...
08-Dec-2000 - Novartis Oncology announced clinical findings from two studies presented today at the 23rd Annual San Antonio Breast Cancer Symposium. The findings show Femara® (letrozole tablets) to be significantly more effective than tamoxifen in treating postmenopausal women with advanced breast cancer in ...
04-Dec-2000 - Novartis Oncology today announced that data on Glivec™, formerly STI571, will be featured in more than 50 abstracts this week at the annual meeting of The American Society of Hematology (ASH) in San Francisco. Glivec is an investigational treatment for certain forms of leukemia. The data offer ...
Technology Licensed From OXiGENE, Inc.
30-Nov-2000 - Bristol-Myers Squibb Company (NYSE: BMY), a world leader in oncology, and OXiGENE, Inc. (Nasdaq: OXGN, SSE: OXGN), a world leader in the field of vascular targeting, today reported on an Investigational New Drug (IND) submission for the systemic use of Combretastatin A4 Prodrug (CA4P). ...
24-Oct-2000 - FREMONT, Calif., Oct. 23, 2000 – Abgenix, Inc. (NASDAQ: ABGX) today reported a net income of $1.5 million or $0.02 per share for the quarter ended September 30, 2000, compared to a net loss of $1.3 million or $0.02 per share for the quarter ended September 30, 1999. Contract revenues for the ...
11-Oct-2000 - CAMBRIDGE, Mass., Oct. 10 Biogen, Inc. (Nasdaq: BGEN) today reported financial results for the third quarter of 2000. For the three months ended September 30, 2000, the Company reported net income of $68,381,000, an increase of 10 percent compared to the same period in 1999, resulting in $0.44 ...
04-Oct-2000 - Cambridge, USA, Martinsried/Munich, Germany, October 2, 2000 MorphoSys AG (Neuer Markt: MOR), the German biotechnology company based in Munich/Martinsried, today announced a collaboration with ImmunoGen, Inc. (NASDAQ: IMGN), a Cambridge, Massachusetts-based biotechnology company. The two ...
© 1997-2024 LUMITOS AG, All rights reserved